For artificial intelligence-assisted digital hematopathology, SigTuple’s AI100 is the premier solution
Artificial intelligence-powered technology (SigTuple’s AI100) has been adopted by HealthCare Global Enterprises Ltd (HCG) to automate the manual microscopy (screening) process across its network. For cancer detection and disease management, this makes HCG the first hospital chain to equip the hematopathology labs across its network with artificial intelligence-powered screening solutions.
For artificial intelligence-assisted digital hematopathology, SigTuple’s AI100 is the premier solution. Economical and robust enough for wide-scale adoption, it is also the only digital hematopathology solution available.
Commenting on the new artificial intelligence based solution, Dr BS Ajaikumar, Executive Chairman, HCG said, “AI-assisted digital scanning technology has indeed emerged as a game-changer in cancer care. Sigtuple’s best-in-class solution has brought remarkable precision to HCG’s hematopathology diagnostic capabilities. The automation of key processes and optimization of logistics by virtue of this pioneering technology is a distinct value-add for HCG, given our overarching goal of serving the larger cause of patients through enhanced clinical outcomes.”
On the deployment of AI100, Tathagato Rai Dastidar, Founder and CEO, SigTuple stated, “AI100 was built to solve the problem of digital pathology with that aim in mind. Having gone through a rigorous evaluation process at HCG and coming out on the top is a strong validation of the quality of the product built by the team. We compete head-on with the global companies in the digital cell morphology space and are able to offer much more than the competition and at significantly lower costs.”
Informing that world over, artificial intelligence assisted digital scanning technology is the way forward for pathology, the medtech compnay informed that digital scanning technology makes it possible for pathologists to review samples remotely, without having to ship them to the reference laboratory, as the digital conversion can happen at site. This collaboration is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold.
Further added, this solution will enable pathologists to collaborate seamlessly across geographies thereby ensuring that every HCG centre will now get access to expertise across the network within seconds.
Also read: Women can not only work in technology but also rise to positions of power
Do Follow: CIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter
About us:
CIO News, a proprietary of Mercadeo, produces award-winning content and resources for IT leaders across any industry through print articles and recorded video interviews on topics in the technology sector such as Digital Transformation, Artificial Intelligence (AI), Machine Learning (ML), Cloud, Robotics, Cyber-security, Data, Analytics, SOC, SASE, among other technology topics
